title: Enhanced NK activity during blast crisis in chronic myelogenous leukemia (CML)
authors.forename: V
authors.initials: V
authors.lastname: Delwail
authors.forename: A
authors.initials: A
authors.lastname: Meseri
authors.forename: A
authors.initials: A
authors.lastname: Brizard
authors.forename: J C
authors.initials: JC
authors.lastname: Lecron
authors.forename: A
authors.initials: A
authors.lastname: Sadoun
authors.forename: F
authors.initials: F
authors.lastname: Costerousse
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: J
authors.initials: J
authors.lastname: Tanzer
authors.forename: P
authors.initials: P
authors.lastname: Goube de Laforest
mesh_terms: D001752:Blast Crisis / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology* / Q000473:pathology; D008875:Middle Aged